Search

everythinglearnresearchcommunity

for

Search:↓

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Nanotechnology improves minoxidil treatment for hair loss.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Facial aging is caused by natural processes and external factors, and can be managed with preventative measures and a variety of treatments tailored to individual needs.

Minoxidil boosts hair growth by increasing blood flow and nutrients to hair follicles.

An extra-strength marine protein supplement helped increase hair growth and decrease hair shedding in women with thinning hair.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

More research is needed to determine if iron deficiency causes hair loss.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Acne is an important sign of androgen excess disorders in women.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Researchers developed a reliable method to measure testosterone and epitestosterone in urine for medical and anti-doping use.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

New drugs are improving treatment for hormone-related diseases in small pets.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Certain zinc transporters are essential for healthy skin and managing zinc in the body could help treat skin problems.